Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Breast Neoplasms 23Triple Negative Breast Neoplasms 17Ovarian Neoplasms 17Endometrial Neoplasms 17Lung Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 13Fallopian Tube Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Neoplasm Metastasis 9Neoplasms 6Esophageal Neoplasms 6Adenocarcinoma Of Esophagus 6Stomach Neoplasms 4Melanoma 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Carcinoma 4Uterine Cervical Neoplasms 3Peritoneal Neoplasms 3Colorectal Neoplasms 3Adenocarcinoma 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Respiratory Tract Neoplasms 2Pathologic Complete Response 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Lung Diseases 2Laryngeal Neoplasms 2

Interventions

enasidenib 1capivasertib 1Taxes 1Paclitaxel 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × Paclitaxel × 30 days × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡